Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of (a) hospitalisations and (b) deaths that have been prevented by RSV vaccines administered through the early adopter community pharmacy sites.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

People are eligible for the respiratory syncytial virus (RSV) vaccination if they are pregnant, from 28 weeks onwards, or if they are aged 75 to 79 years old.

Some people aged 75 to 79 years old have been able to receive the RSV vaccine from a small number of community pharmacy pilot sites in the East of England. Approximately 8,000 individuals received their RSV vaccine in these community pharmacies between October and November 2024. The majority of the programme was delivered in general practice.

Overall, the UK Health Security Agency’s (UKHSA) findings indicate that there were 30% fewer hospital admissions in 75 to 79 year olds, who are eligible for the vaccine under the new programme, than there would have been without vaccination. This was seen after approximately 40% of eligible older people took up the vaccine this winter, and the impact is expected to increase with further vaccine uptake.

A UKHSA-led evaluation of the expansion of the community pharmacy RSV vaccination pilot is underway, covering a further 200 sites.

Question to the Department for Education:

To ask the Secretary of State for Education, whether she plans to include (a) financial and (b) other citizenship education in the school syllabus.

Answered by Catherine McKinnell

The national curriculum for citizenship equips pupils to manage their money effectively and provides a framework to explore a range of important concepts to prepare pupils for adulthood, such as democracy, human rights, justice, media literacy, the law, and the need for mutual respect.

The government has established an independent Curriculum and Assessment Review, covering ages 5 to 18, chaired by Professor Becky Francis CBE. During their public consultation, the Review Group heard consistently from parents and children that they want more focus on the applied knowledge and skills that will equip them for later life and work, such as financial education. The Review is considering whether there is sufficient coverage of these skills within subjects, and how content can remain relevant and support young people to thrive in a fast-changing world.

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, what plans his Department has to introduce a national animal welfare labelling scheme.

Answered by Daniel Zeichner

I refer the hon. Member to the reply given to the hon. Member for Rotheram, Sarah Champion, on 3 July 2025, PQ 62951.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2025 to Question 54542 on Drug Prices, how many of the commercial arrangements involving indications-specific pricing were for indications for (a) rare and (b) ultra-rare cancers.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

Between January 2020 and March 2025, NHS England entered into 62 commercial agreements involving indication-specific pricing for cancer indications. Of these:

• 60 were for indications classified as rare; and
• of those 60, two were for indications classified as ultra-rare.

NHS England determines whether a cancer indication is considered rare or ultra-rare based on the incidence of the eligible patient population for a given National Institute for Health and Care Excellence Technology Appraisal, rather than the overall incidence of the broader cancer type. The following definitions have been applied:

• rare, with fewer than six cases per 100,000 population per year; and
• ultra-rare, with one case per 1,000,000 population per year or fewer.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to Action 28 (i) of the Life Sciences Sector Plan, published on 16 July 2025, what criteria his Department plans to use to identify (a) low affordability risk and (b) strong long-term outcome data, in the context of identifying eligibility for the proportionate approach to indication-specific pricing agreements.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The criteria will be developed alongside the new proportionate approach to indication-specific pricing arrangements.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to Action 28 (i) of the Life Sciences Sector Plan, published on 16 July 2025, what criteria his Department plans to use to identify which medicines have a large number of indications, in the context of identifying eligibility for the proportionate approach to indication-specific pricing agreements.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The criteria will be developed alongside the new proportionate approach to indication-specific pricing arrangements.

Eating disorders and online harms

Found: transparency about what substances are used and how they are stored, prescribed and delivered”.34 Sadik Al-Hassan

Found: transparency about what substances are used and how they are stored, prescribed and delivered”.34 Sadik Al-Hassan

Sustainable Plastics APPG
Wednesday 27th August 2025

Found: APPG IGM Attendees: Baroness Grender Earl Russell Andrew Cooper MP Laurence Turner MP Sadik al Hassan